SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (651)3/29/2001 8:22:01 AM
From: nigel bates   of 7143
 
newscientist.com
Huntington's disease may have an Achilles heel, say US researchers. They have discovered the key to the molecular mechanism that kills afflicted brain cells...

...."We can essentially completely block huntington toxicity," says Ross. This proves in principle that the interaction between polyglutamine tracts could be targeted with drugs. "We think this is a very feasible and practical therapeutic target," he says.
More at: Science (vol 291, 2423)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News